国产呻吟久久久久久久92,久久久久国色aV免费观看不卡

當(dāng)前位置: 首頁 » 產(chǎn)品 » 搜索

AZD 6482
產(chǎn)品描述：AZD6482 is a PI3K inhibitor with IC50 of 10 nM, 8-, 87- and 109-fold more selective to PI3K than PI3K, PI3K an
2015-11-09 13:45 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

2260.00/10mg
010mg起訂

Sotrastaurin
產(chǎn)品描述：Sotrastaurin(AEB-071) is a potent and selective pan-PKC inhibitor, mostly for PKC with Ki of 0.22 nM; inactive
2015-11-09 13:44 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

2046.00/10mg
010mg起訂

Enzastaurin
產(chǎn)品描述：Enzastaurin (LY317615) is a potent PKC selective inhibitor with IC50 of 6 nM, 6- to 20-fold selectivity agains
2015-11-09 13:29 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

884.00/10mg
010mg起訂

Fasudil
產(chǎn)品描述：Fasudil Hcl(HA-1077; AT-877) is a potent inhibitor of ROCK-II, PKA, PKG, PKC, and MLCK with Ki of 0.33 M, 1.6
2015-11-09 13:28 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

1252.00/500mg
0500mg起訂

KX2-391 (dihydrochloride)
產(chǎn)品描述：KX2-391 2Hcl (KX01) is the first clinical Src inhibitor (peptidomimetic class) that targets the peptide substr
2015-11-09 13:26 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

663.00/5mg
05mg起訂

廠家直銷優(yōu)質(zhì)高效皮草加工污水處理設(shè)備/18263616608
本公司結(jié)合所做的污水工程經(jīng)驗，按國家相關(guān)的排放標(biāo)準(zhǔn)，對該項目做以下具體的方案設(shè)計，為用戶提供較為理想、投資省、處理效果好
2015-11-09 10:19 [山東濰坊市]
山東尚清環(huán)?？萍加邢薰?/a> [已核實]

面議

KX2-391
產(chǎn)品描述：KX2-391 (KX01), the first clinical Src inhibitor (peptidomimetic class) that targets the peptide substrate sit
2015-11-06 15:25 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

663.00/5mg
05mg起訂

KW-2449
產(chǎn)品描述：KW-2449 is a multiple-targeted inhibitor, mostly for Flt3 with IC50 of 6.6 nM, modestly potent to FGFR1, Bcr-A
2015-11-06 15:24 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

663.00/10mg
010mg起訂

Foretinib
產(chǎn)品描述：Foretinib (GSK1363089; XL880; EXEL-2880; GSK089) is an ATP-competitive inhibitor of HGFR and VEGFR, mostly for
2015-11-06 15:23 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

1948.00/10mg
010mg起訂

Brivanib
產(chǎn)品描述：Brivanib(BMS540215) is an ATP-competitive inhibitor against VEGFR2 with IC50 of 25 nM, moderate potency agains
2015-11-06 15:22 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

1252.00/5mg
05mg起訂

Brivanib (alaninate)
產(chǎn)品描述：Brivanib alaninate(BMS582664) is an ATP-competitive inhibitor against VEGFR2 with IC50 of 25 nM, moderate pote
2015-11-06 15:21 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

3537.00/10mg
010mg起訂

BMS-690514
產(chǎn)品描述：BMS-690514 is a potent and selective inhibitor of epidermal growth factor receptor (EGFR), HER2, and HER4, as
2015-11-06 15:20 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

3580.00/10mg
010mg起訂

Regorafenib (monohydrate)
產(chǎn)品描述：Regorafenib (BAY 73-4506) is a multi-target inhibitor for VEGFR1, VEGFR2, VEGFR3, PDGFR, Kit, RET and Raf-1 wi
2015-11-06 15:19 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

860.00/10mg
010mg起訂

Regorafenib
產(chǎn)品描述：Regorafenib (BAY 73-4506) is a multi-target inhibitor for VEGFR1, VEGFR2, VEGFR3, PDGFR, Kit, RET and Raf-1 wi
2015-11-06 15:18 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

2100.00/50mg
050mg起訂

Toceranib (phosphate)
產(chǎn)品描述：Toceranib phosphate (SU 11654; PHA 291639) is a kinase inhibitor with both antitumor and antiangiogenic activi
2015-11-06 15:17 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

1674.00/10mg
010mg起訂

Toceranib
產(chǎn)品描述：Toceranib(SU 11654; PHA 291639) is a kinase inhibitor with both antitumor and antiangiogenic activity through
2015-11-06 15:16 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

1674.00/10mg
010mg起訂

JNJ-7706621
產(chǎn)品描述：JNJ-7706621 is pan-CDK inhibitor with the highest potency on CDK1/2 with IC50 of 9 nM/4 nM and showing 6-fold
2015-11-06 15:15 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

1507.00/5mg
05mg起訂

VX-745
產(chǎn)品描述：VX-745 is a potent and selective inhibitor of p38 with IC50 of 10 nM, 22-fold greater selectivity versus p38 a
2015-11-06 15:14 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

1440.00/10mg
010mg起訂

GW788388
產(chǎn)品描述：GW788388 is a potent and selective inhibitor of ALK5 with IC50 of 18 nM, also inhibits TGF- type II receptor a
2015-11-06 15:13 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]

623.00/5mg
05mg起訂

CL-387785
產(chǎn)品描述：CL-387785(EKI785; WAY-EKI 785) is an irreversible inhibitor of EGFR with IC50 of 370+/-120 pM; is able to over
2015-11-06 15:12 [上海]
上海皓元生物醫(yī)藥科技有限公司 [已核實]